LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the safety and tolerability of ascending single and
multiple oral doses of LEO 27847 in secondary hyperparathyroidism patients.